A previous study by the ADARC and Rockefeller team in collaboration with ViiV Healthcare and GSK found long-acting cabotegravir could protect male rhesus macaque monkeys from exposure to a virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback